Skip to main content
Atrás
Watch Compare

Nautilus Biotechnology, Inc.

Calidad de datos: 83%
NAUT
Nasdaq Manufacturing Measuring & Analyzing Instruments
$2.95
▼ $0.09 (-2.96%)
Cap. Mercado: 406.27 M
Precio
$3.21
Cap. Mercado
406.27 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -51.97 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-33.69%
Above sector avg (-53.47%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio14.95
Interest CoverageN/A

Valoración

PE (TTM)
-6.89
Below sector avg (-1.48)
P/B Ratio2.40
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -6.9 -1.5
P/B 2.4 1.6
ROE % -33.7 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

1 analista
Buy
Actual
$2.95
+35.6%
Objetivo
$4.00
$4.00
$4.00
$4.00
Pronóstico
EPS Futuro -$0.55
Ingresos Est. 7.65 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.55
-$0.66 – -$0.44
 7.65 M 2
FY2026 -$0.55
-$0.57 – -$0.53
 700,000.0 2

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.14 -$0.11 +21.4%
Q32025 -$0.15 -$0.11 +26.7%
Q22025 -$0.14 -$0.12 +14.3%
Q12025 -$0.14 -$0.13 +4.9%

ETFs Holding This Stock

BRSIX BRSIX
0.04% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -59.00 M
ROE -33.69% ROA -28.50%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51.97 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 14.95
Interest Coverage N/A Asset Turnover N/A
Working Capital 125.34 M Tangible Book Value 169.14 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6.89 Forward P/E N/A
P/B Ratio 2.40 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -12.79%
Market Cap 406.27 M Enterprise Value 382.40 M
Per Share
EPS (Diluted TTM) -0.47 Revenue / Share N/A
FCF / Share -0.41 OCF / Share -0.40
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 88.09%
SBC-Adj. FCF -60.53 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue — — — — —
Net Income -59.00 M -70.78 M -63.68 M -57.92 M -523,083.0
EPS (Diluted) -0.47 -0.56 -0.51 -0.46 —
Gross Profit — — — — —
Operating Income — — — — -576,035.0
EBITDA — — — — —
R&D Expenses 41.11 M 50.48 M 47.25 M 37.67 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 191.11 M 242.74 M 305.57 M 350.05 M 150.86 M
Total Liabilities 34.14 M 34.01 M 40.21 M 35.13 M 5.62 M
Shareholders' Equity 156.97 M 208.73 M 265.35 M 314.92 M 5.00 M
Total Debt — — — — —
Cash & Equivalents 12.39 M 27.65 M 19.40 M 114.52 M —
Current Assets 105.96 M 132.83 M 176.84 M 187.21 M 1.30 M
Current Liabilities 7.95 M 7.63 M 9.12 M 6.79 M 388,507.0